Skip to main content

Table 1 Clinico-pathological characteristics, viral DNA load and plasma concentration of miR-BART17 normalized with miR-cel-39 for samples from NPC patients

From: Consistent high concentration of the viral microRNA BART17 in plasma samples from nasopharyngeal carcinoma patients - evidence of non-exosomal transport

Patient Gender/age Origin First occurrence (FO) or Relapse(R) TNM Histology EBV DNA copy number/ml miR BART17 copy number/ml
1 M/59 France FO cT4N2M0 NKUC 1559 26
2 M/43 Morocco R rT0N0M1 NKUC 7065 148
3 M/55 Cambodia FO cT3N0M0 NKUC 28 1226
4 M/40 Algeria FO cT4N1M0 NKUC 325 8014
5 M/61 Algeria FO cT2N2M0 NKUC 466 279
6 M/47 China FO cT2N0M0 NKUC 0 4501
7 F/34 Sweden FO cT2N3aM1 NKUC 67 11087
8 F/47 Tunisia FO cT2N1M0 NKDC 0 739
9 M/40 North Africa FO cT1N3bM0 NKUC 40 8824
10 M/51 North Africa FO cT3N2M1 NKUC 1142 242506
11 M/41 Turkey R rTXN1M0 KSCC 79 128426
12 M/49 France FO cT3N1M0 NKUC 0 2725
13 M/65 France R rT2N3bM0 NKUC 0 448961
14 M/58 Tunisia FO* cT2N0M0 NKUC 351 589
15 M/41 Tunisia FO* cT3N2M0 NKUC 1475 4889
16 F/49 France FO cT2N2M0 NKUC 9 205985
17 F/39 Morocco FO cT4N1M0 NKUC 0 1080
18 M/62 Algeria R* rT4N0M0 NKUC 328 161
19 M/66 Algeria R rT0N2M0 NKUC 31 25788
20 M/47 Cameroon R rTXN2M1 NKUC 21 42
21 M/58 Cameroon R* cT2bN1M1 NKUC 8 3220
22 M/60 Morocco R rT1N2M0 NKUC 136 4401
23 M/59 Algeria R rT1NxM0 NKUC 0 2465
24 M/58 Algeria FO* cT1N3bM0 NKUC 20 11
25 F/40 France R rT0N0M1 NKUC 0 155002
26 M/61 Cameroon R* rT4N0M0 NKUC 0 19881
  1. Samples were collected prior to any treatment (FO), without any treatment in the previous last 6 months (R) or from patients under chemotherapy or chemo-radiotherapy (FO* and R*). All patients had active disease at the time of blood sample collection. NKUC: non keratinizing undifferentiated carcinoma; NKDC: non-keratinizing differentiated carcinoma; KSCC: keratinizing squamous cell carcinoma.